{'fraction_non_alphanumeric': 0.02838709677419355, 'fraction_numerical': 0.007741935483870968, 'mean_word_length': 5.807017543859649, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Extended VTE Prophylaxis in Morbidly Obese Patients Who Underwent Robotic Surgery For Endometrial Cancer [31A]

INTRODUCTION: Robotic surgery for gynecologic malignancy is associated with a lower rate of venous thromboembolism (VTE) than laparotomy. However, guidelines for extended-duration thromboprophylaxis (e.g. 4 weeks) following robotic surgery for gynecologic malignancy are unclear. Obese patients (BMI .35Kg/m2) represent a particularly high-risk group for VTE, but prior studies regarding extended thromboprophylaxis after robotic surgery tend to focus on patients with a much lower average BMI. This study aimed to examine the role of extended post-operative thromboprophylaxis in morbidly obese patients who underwent robotic hysterectomy for endometrial cancer.